FierceBiotech 2026-01-08 Longtime Charles River leader Jim Foster to retire, with COO set to take the helm
FierceBiotech 2026-01-08 Lexeo Therapeutics, J&J team up to test heart pump technology for cardiac gene therapy delivery
FierceBiotech 2026-01-08 Immuneering touts 64% 1-year survival, keeping wheels turning in race with Revolution
FierceBiotech 2026-01-08 Diagonal moves forward with $125M series B round, plots first-in-human study this year
FierceBiotech 2026-01-08 WEP Clinical grabs European CRO Siron Clinical, broadening global capabilities
FierceBiotech 2026-01-08 Lilly links up with InduPro in next-gen cancer treatment deal worth up to $950M
FierceBiotech 2026-01-07 Pulmocide calls curtains on phase 3 antifungal trial over low response, higher mortality rate
FierceBiotech 2026-01-07 Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus’ replication
FierceBiotech 2026-01-07 Staar Surgical's takeover saga ends as shareholder revolt stops Alcon’s attempted merger deal
FierceBiotech 2026-01-07 Fierce Biotech Fundraising Tracker '26: Soley sees $200M series C; Rakuten rakes in $100M
FierceBiotech 2026-01-07 GSK's 'functional cure' for hep B proves worth in phase 3 trials setting up approval push